Correlation Between Alto Neuroscience, and Biohaven Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Alto Neuroscience, and Biohaven Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alto Neuroscience, and Biohaven Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alto Neuroscience, and Biohaven Pharmaceutical Holding, you can compare the effects of market volatilities on Alto Neuroscience, and Biohaven Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alto Neuroscience, with a short position of Biohaven Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alto Neuroscience, and Biohaven Pharmaceutical.
Diversification Opportunities for Alto Neuroscience, and Biohaven Pharmaceutical
-0.41 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Alto and Biohaven is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Alto Neuroscience, and Biohaven Pharmaceutical Holdin in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biohaven Pharmaceutical and Alto Neuroscience, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alto Neuroscience, are associated (or correlated) with Biohaven Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biohaven Pharmaceutical has no effect on the direction of Alto Neuroscience, i.e., Alto Neuroscience, and Biohaven Pharmaceutical go up and down completely randomly.
Pair Corralation between Alto Neuroscience, and Biohaven Pharmaceutical
Given the investment horizon of 90 days Alto Neuroscience, is expected to under-perform the Biohaven Pharmaceutical. In addition to that, Alto Neuroscience, is 1.77 times more volatile than Biohaven Pharmaceutical Holding. It trades about -0.03 of its total potential returns per unit of risk. Biohaven Pharmaceutical Holding is currently generating about 0.06 per unit of volatility. If you would invest 2,313 in Biohaven Pharmaceutical Holding on August 31, 2024 and sell it today you would earn a total of 2,288 from holding Biohaven Pharmaceutical Holding or generate 98.92% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 56.42% |
| Values | Daily Returns |
Alto Neuroscience, vs. Biohaven Pharmaceutical Holdin
Performance |
| Timeline |
| Alto Neuroscience, |
| Biohaven Pharmaceutical |
Alto Neuroscience, and Biohaven Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Alto Neuroscience, and Biohaven Pharmaceutical
The main advantage of trading using opposite Alto Neuroscience, and Biohaven Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alto Neuroscience, position performs unexpectedly, Biohaven Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biohaven Pharmaceutical will offset losses from the drop in Biohaven Pharmaceutical's long position.| Alto Neuroscience, vs. Datadog | Alto Neuroscience, vs. ServiceNow | Alto Neuroscience, vs. FiscalNote Holdings | Alto Neuroscience, vs. Amkor Technology |
| Biohaven Pharmaceutical vs. Immunome | Biohaven Pharmaceutical vs. Inhibrx | Biohaven Pharmaceutical vs. Day One Biopharmaceuticals | Biohaven Pharmaceutical vs. Terns Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |